Sanbox:Kamal: Difference between revisions
Jump to navigation
Jump to search
Kamal Akbar (talk | contribs) No edit summary |
Kamal Akbar (talk | contribs) No edit summary |
||
Line 91: | Line 91: | ||
* Elevated LDH | * Elevated LDH | ||
* T-cell deficiency leading immunodeficiency causing opportunistic infection | * T-cell deficiency leading immunodeficiency causing opportunistic infection | ||
| align="center" style="background:#F5F5F5;" + |+ | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 122: | Line 122: | ||
** [[Bone pain]] | ** [[Bone pain]] | ||
** Painless swelling in the neck, axilla, groin, thorax, and abdomen | ** Painless swelling in the neck, axilla, groin, thorax, and abdomen | ||
| align="center" style="background:#F5F5F5;" + |+ | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |+ | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 133: | Line 133: | ||
* Strongly immunoreactive for [[CD30]], Anaplastic lymphoma kinase (ALK), EMA, and [[vimentin]] | * Strongly immunoreactive for [[CD30]], Anaplastic lymphoma kinase (ALK), EMA, and [[vimentin]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* | |||
* Nucleoli tend to be more prominent | |||
* The cytoplasm may be either [[basophilic]] or [[eosinophilic]] and the cell might have many nuclei with dispersed or clumped [[chromatin]] | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | |
Revision as of 15:15, 21 January 2019
==References==
Differentiating NHL
Category | Disease | Etiology | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | Mass | Other | WBC | Hb | Plt | Immunochemistry | Histopathology | Gold standard | Associated findings | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
T cell lymphoma | Precursor T-cell lymphoblastic leukemia/lymphoma |
|
||||||||||||||
T-cell granular lymphocytic | ||||||||||||||||
T-cell prolymphocytic leukemia | ||||||||||||||||
Adult T cell leukemia/lymphoma[1][2][3] |
|
|
+ |
|
Hypercalcemia | |||||||||||
Anaplastic large cell lymphoma |
|
|
+ | + |
|
|||||||||||
Cutaneous T-cell lymphoma | Mycosis fungoides / Sézary syndrome |
|
|
|
||||||||||||
Peripheral T-cell lymphoma | Subcutaneous panniculitis-like T-cell lymphoma |
|
||||||||||||||
Hepatosplenic T-cell lymphoma |
|
|||||||||||||||
Enteropathy-type intestinal T-cell lymphoma |
|
|||||||||||||||
Extranodal T-cell lymphoma, nasal type |
|
|||||||||||||||
Angioimmunoblastic T-cell lymphoma |
|
|||||||||||||||
Peripheral T-cell lymphoma, unspecified |
|
- ↑ Matutes E (2007). "Adult T-cell leukaemia/lymphoma". J. Clin. Pathol. 60 (12): 1373–7. doi:10.1136/jcp.2007.052456. PMC 2095573. PMID 18042693.
- ↑ Matutes E (2007) Adult T-cell leukaemia/lymphoma. J Clin Pathol 60 (12):1373-7. DOI:10.1136/jcp.2007.052456 PMID: 18042693
- ↑ Shimoyama M (1991). "Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)". Br J Haematol. 79 (3): 428–37. PMID 1751370.